Active Ingredient History
Erythropoietin, also known as erythropoetin, haematopoietin, or haemopoietin, is a glycoprotein cytokine secreted mainly by the kidneys in response to cellular hypoxia; it stimulates red blood cell production (erythropoiesis) in the bone marrow. Low levels of EPO are constantly secreted in sufficient quantities to compensate for normal red blood cell turnover. Common causes of cellular hypoxia resulting in elevated levels of EPO include any anemia, and hypoxemia due to chronic lung disease and mouth disease. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia (approved 1989)
Acquired Immunodeficiency Syndrome (Phase 2)
Acute Febrile Encephalopathy (Phase 3)
Acute Kidney Injury (Phase 2)
Acute-On-Chronic Liver Failure (Phase 3)
Aged (Phase 2)
Aging (Phase 2)
Allografts (Phase 3)
Altitude Sickness (Phase 4)
Amyotrophic Lateral Sclerosis (Phase 2)
Anemia (Phase 4)
Anemia, Iron-Deficiency (Phase 4)
Anemia, Neonatal (Phase 2/Phase 3)
Anemia, Sickle Cell (Phase 1/Phase 2)
Angiogenesis Modulating Agents (Phase 2)
Angioplasty, Balloon, Coronary (Phase 3)
Aorta (Phase 4)
Aortic Diseases (Phase 1/Phase 2)
Aortic Valve Stenosis (Phase 3)
Arteries (Phase 1/Phase 2)
Arthritis, Rheumatoid (Phase 2)
Arthropathy, Neurogenic (Phase 2)
Aspergillosis, Allergic Bronchopulmonary (Phase 3)
Asphyxia (Phase 3)
Atherosclerosis (Phase 4)
Autoimmune Diseases (Phase 4)
beta-Thalassemia (Phase 2/Phase 3)
Bipolar Disorder (Phase 2)
Blood Transfusion (Phase 3)
Blood Transfusion, Autologous (Phase 3)
Brain Diseases (Phase 3)
Brain Injuries (Phase 2)
Brain Injuries, Traumatic (Phase 3)
Breast Neoplasms (Phase 4)
Carcinoma (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Cardiovascular Diseases (Phase 4)
Cardiovascular Surgical Procedures (Phase 2/Phase 3)
Cerebral Intraventricular Hemorrhage (Phase 2)
Cerebral Palsy (Phase 3)
Chemotherapy, Adjuvant (Phase 3)
Cognitive Dysfunction (Phase 2)
Conjunctivitis (Phase 2/Phase 3)
Coronary Artery Bypass (Phase 2)
Coronary Artery Disease (Phase 2)
Critical Care (Phase 3)
Critical Illness (Phase 2)
Cyanosis (Phase 2)
Delayed Graft Function (Phase 4)
Depressive Disorder (Phase 2)
Diabetes Mellitus, Type 2 (Phase 1/Phase 2)
Diabetic Foot (Phase 2)
Diabetic Nephropathies (Phase 4)
Dialysis (Phase 4)
Drug Evaluation (Phase 3)
Drug Resistance (Phase 3)
Drug Therapy (Phase 4)
Electroconvulsive Therapy (Phase 2)
Enterocolitis, Necrotizing (Phase 1/Phase 2)
Epoetin Alfa (Phase 2)
Erectile Dysfunction (Phase 2)
Erythrocyte Transfusion (Phase 4)
Erythropoietin (Phase 3)
Esophageal Neoplasms (Phase 3)
Exercise (Phase 4)
Fallopian Tube Neoplasms (Phase 2)
Fatigue (Phase 4)
Feeding and Eating Disorders (Phase 1/Phase 2)
Fetal Blood (Phase 1/Phase 2)
Friedreich Ataxia (Phase 2)
Gastrointestinal Neoplasms (Phase 3)
General Surgery (Phase 2)
Genital Neoplasms, Female (Phase 2)
Growth and Development (Phase 2)
Hamartoma (Phase 4)
Head and Neck Neoplasms (Phase 3)
Healthy Volunteers (Phase 2)
Heart Arrest (Phase 3)
Heart Defects, Congenital (Phase 2)
Heart Diseases (Phase 3)
Heart Failure (Phase 4)
Heart Valve Diseases (Phase 1/Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 4)
Hemodialysis, Home (Phase 3)
Hemoglobins (Phase 3)
Hemolytic-Uremic Syndrome (Phase 4)
Hemorrhagic Stroke (Phase 1/Phase 2)
Hemostasis, Surgical (Phase 4)
Hepacivirus (Phase 4)
Hepatitis A ()
Hepatitis, Autoimmune (Early Phase 1)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 3)
Hip Fractures (Phase 3)
HIV (Phase 2)
HIV Infections (Phase 4)
Hodgkin Disease (Phase 3)
Hypertension (Phase 4)
Hypertension, Pulmonary (Phase 1)
Hypertrophy, Left Ventricular (Phase 3)
Hypoplastic Left Heart Syndrome (Phase 1/Phase 2)
Hypoxia (Phase 4)
Hypoxia-Ischemia, Brain (Phase 3)
Infant, Low Birth Weight (Phase 2/Phase 3)
Infant, Newborn (Phase 2/Phase 3)
Infant, Premature (Phase 3)
Infant, Premature, Diseases (Phase 3)
Infant, Small for Gestational Age (Phase 2/Phase 3)
Infarction, Middle Cerebral Artery (Phase 2/Phase 3)
Intestinal Neoplasms (Phase 3)
Intracranial Hemorrhages (Phase 3)
Iron Deficiencies (Phase 4)
Ischemic Attack, Transient (Phase 1/Phase 2)
Ischemic Stroke (Phase 2)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Kidney Transplantation (Phase 2/Phase 3)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 3)
Leukomalacia, Periventricular (Phase 3)
Lichen Planus, Oral (Phase 3)
Live Birth (Phase 3)
Liver Failure (Phase 3)
Liver Transplantation (Phase 4)
Lung Diseases (Phase 3)
Lung Neoplasms (Phase 3)
Lymphoid Tissue (Phase 4)
Lymphoma (Phase 4)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoproliferative Disorders (Phase 3)
Macular Edema (Phase 2/Phase 3)
Malaria, Cerebral (Phase 2/Phase 3)
Malnutrition (Phase 4)
Mammaplasty (Phase 2/Phase 3)
Methylprednisolone (Phase 2/Phase 3)
Mood Disorders (Phase 2)
Moyamoya Disease (Phase 1/Phase 2)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 2)
Multiple Trauma (Phase 3)
Myelodysplastic Syndromes (Phase 4)
Myeloproliferative Disorders (Phase 3)
Myocardial Infarction (Phase 4)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 4)
Nephrology (Phase 3)
Nerve Compression Syndromes (Phase 2/Phase 3)
Neurosurgeons (Phase 1/Phase 2)
Neutropenia (Phase 4)
Optic Nerve Diseases (Phase 3)
Optic Nerve Injuries (Phase 3)
Optic Neuritis (Phase 3)
Optic Neuropathy, Ischemic (Phase 2)
Orthopedic Procedures (Phase 3)
Osteoarthritis (Phase 4)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 2)
Parkinson Disease (Phase 1/Phase 2)
Peripheral Nerve Injuries (Phase 2)
Peritoneal Neoplasms (Phase 2)
Physical Functional Performance (Phase 4)
Platinum Compounds (Phase 3)
Postoperative Complications (Phase 4)
Precancerous Conditions (Phase 3)
Premature Birth (Phase 4)
Prostate (Phase 3)
Prostatic Neoplasms (Phase 3)
Psychomotor Disorders (Phase 2)
Quality of Life (Phase 3)
Rectal Neoplasms (Phase 3)
Renal Dialysis (Phase 4)
Renal Insufficiency (Phase 3)
Renal Insufficiency, Chronic (Phase 4)
Reperfusion Injury (Phase 2)
Resuscitation (Phase 3)
Retinopathy of Prematurity (Phase 1/Phase 2)
Safety (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Spinal Cord Injuries (Phase 3)
Stomach Neoplasms (Phase 3)
Stroke (Phase 2/Phase 3)
Subarachnoid Hemorrhage (Phase 4)
Substance Abuse, Oral (Phase 1)
Therapeutics (Phase 2/Phase 3)
Thoracic Surgery (Phase 2)
Thrombosis (Phase 4)
Toxicity Tests (Phase 1/Phase 2)
Toxic Optic Neuropathy (Phase 2/Phase 3)
Traumatology (Phase 3)
Treatment Outcome (Phase 1/Phase 2)
Urological Manifestations (Phase 1/Phase 2)
Uterine Cervical Neoplasms (Phase 3)
Venous Thrombosis (Phase 3)
Wounds and Injuries (Phase 3)
Wounds, Nonpenetrating (Phase 3)
Wounds, Penetrating (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue